(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software

His work focuses on developing novel β₂-adrenergic ligands that selectively engage signaling pathways entrepreneur and founder of biotechnology companies translating GPCR pharmacology into therapeutic development Another company, Atrogi, is based on our research on β₂-adrenergic receptors and the development of new

She developed expertise over the past two decades studying structure/function relationships of GPCRs

Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour

Her research centers on developing nanobody-ligand conjugates to target GPCRs, with a focus on receptors

He has developed novel tools and methodologies to study fungal GPCRs which allowed the determination

She is an internationally recognized biophysicist for her contributions in developing constrained molecular

Pydi's laboratory is to develop GPCR-based drugs for the treatment of obesity and Type 2 Diabetes (T2D

The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic development

deciphering of cellular and organ functions, which require individual adhesion GPCRs, and extends to the development

I am continuing with the development of advanced screening approaches in the Madan Babu lab to progress

He argues that staying close to a hot topic feels safe but narrows a scientist's development, and that From undruggable to promising Drug development veterans long treated large adhesive proteins as poor

Lefkowitz , where his research focused on biased agonism, with the development of approaches to quantify

To study GPCR signalling, they develop and use innovative optical methods based on FRET and single-molecule

She developed expertise over the past two decades studying structure/function relationships of GPCRs

to elucidate the role of steroidogenesis in regulating sexual determination and adrenal and gonadal development

Our goal is to deepen our understanding of GPCR function and accelerate the development of better therapies

Develop new tools, training programs, and mentorship programs tailored to your specific needs.

contributions to multiple clinical programs including preclinical models that supported the apixaban development Brian has contributed to the discovery or development of 5 marketed drugs through his work spanning molecular

Trained as a mathematician and computer scientist, his doctoral work focused on developing new methods machine learning since 1989, he built Pharos, the public-facing data platform for the IDG program, and co-developed

In 2018, Bianca was appointed Vice-Chancellor’s Fellow at Queen’s University Belfast to develop her research

the fundamental knowledge of GPCR biology and for the identification of drug targets and future drug development

receptor, and whether that regulatory layer contributes to the therapeutic window problem that GLP-1 drug development Zhao describes how the objective of biased agonism research at the GLP-1 receptor is to develop ligand

I'm genuinely interested to see how it evolves and grows over time, as I feel it has the potential to develop

In 2021 he co-founded Z7 Biotech, developing and providing innovative GPCR drug screening and precision

understand how the principles of receptor allosterism and functional selectivity can be leveraged in the development

Build Trust Develop content that speaks their language and establishes your credibility in the GPCR research

During her time at Providence College, she received the Walsh Grant Fellowship to develop novel methods

Help Us Close the Gap Between Academia and Biotech Together, we can accelerate GPCR discoveries and develop

Aside from his vast experience in drug development, not to mention his extensive publication record,